Unichem Labs gets USFDA nod to Tolterodine Tartrate Tablet to treat overactive bladder

Mumbai: Unichem Laboratories Limited has announced that it has received ANDA approval for its Tolterodine Tartrate Tablets, USP 1 mg and 2 mg from the United States Food and Drug Administration (USFDA) to market a generic version of DETROL® (tolterodine tartrate) tablets of Pfizer Inc.

Tolterodine tartrate tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.

The product will be commercialized from Unichem's Goa Plant.

Read also: Unichem Labs Gets USFDA Nod To Baclofen Tablets For Spasticity Relief

Unichem Laboratories Limited is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in several markets across the world.

Read also: Unichem Labs Irregular Heartbeat Drug Amiodarone Gets USFDA Approval